European Union Trademark Granted for Tauri-Gum (Valid Thru
Year 2029)
European Union Trademark Granted for Tauri-Gummies (Valid
Thru Year 2029)
Pharmaceutical Grade Proposed “Anti-Nausea”
Version of Tauri-Gum (Indication: Nausea Derived from
Ongoing Chemotherapy Treatment)
Assignment of U.S. Provisional Patent to Tauriga Sciences
Inc.
